Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Arch Biopartners Inc V.ARCH

Alternate Symbol(s):  ACHFF

Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury. The Company is developing a platform of new drugs to prevent inflammation injury in the kidneys, lungs and liver via the dipeptidase-1 (DPEP1) pathway and are relevant for many common injuries and diseases where organ inflammation is an unmet problem. The Company’s lead drug candidate is... see more

TSXV:ARCH - Post Discussion

Arch Biopartners Inc > ARCH = Bargain
View:
Post by fourbarrels on Dec 09, 2021 11:22am

ARCH = Bargain

How quickly will buyout offers come in when ARCH has a successful CATCO trial? If you're the acquirer you wont want to wait until $30.00 to make an offer. Good news is insiders have controlling interest and wont sell low.
Comment by 2019champs on Dec 09, 2021 12:49pm
The potential is bigger than $30 a share in my opinion. The Company would probably want to do a kidney trial, as the best data in the animal studies was in the kidney! Any positive data in the kidney and I dont see anything less than $50 a share.
Comment by fourbarrels on Dec 09, 2021 1:47pm
Exactly. If a buyer waits until the stock is at $30.00 the bid would have to be $40.00 to $50.00 to have any chance at getting accepted. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities